Submitted by Anonymous (not verified) on 25 August 2026 - 13:00
Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn
Source:
Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn